Additionally, we show that SRRM2 is exposed on the surface of human cancer cells from different entities and constitutes a novel appealing cancer-associated target molecule, opening the way towards the development of novel SRRM2-targeting cancer therapies. Here, SRRM2 is linked to cancer.